Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INV-001 for prevention of scar after thyroidectomy
NCT05838833Phase 2Unknown
- Sponsor
- Innovo Therapeutics
- Start
- Feb 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of INV-001 in surgical scar, sponsored by Innovo Therapeutics. Status: unknown.
02
Drugs
INV-001
03
Conditions
surgical scar
Beyond the preview
Go deeper on NCT05838833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05838833.